Abraham Heifets of Atomwise is using AI to speed up the development of medications targeted at specific cancer cells
IN ANTICIPATION OF THE 50TH Anniversary of NASA astronauts landing on the moon, Newsweek is spotlighting pioneers in science and technology, highlighting their very own moonshots and how they hope to change the world.
Abraham Heifets is the CEO and co-founder of Atomwise, a biotech company using patented deep learning artificial intelligence technology to predict and discover which drugs will be better, safer and more potent for cancer patients.
Q What is your moonshot?
A To make novel, better and safer drugs, with the ultimate goal to get medicines into the hands of patients faster.
Q How do you do that?
A We’re trying to solve how you modify a cell that’s in the runaway disease process and figure out what’s causing a cell to keep growing and dividing. Think of proteins in your body as machines on the assembly line. If the machine governing cell growth and division breaks and goes haywire, then the cell will keep growing and dividing. That’s a tumor and how cancer happens. If you see a machine going haywire, you’d want to throw in a monkey wrench so the machine is busy chomping on that instead. Today, it takes about 15 years and several billion dollars to find a new drug. Every day that you don’t have good treatment, that’s real people, patients, lives and health in the balance.
Q How does Atomwise go about searching for the right drugs?
هذه القصة مأخوذة من طبعة July 26, 2019 من Newsweek.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة July 26, 2019 من Newsweek.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
America's Maternity Hospitals 2024
The arrival of a healthy baby brings unparalleled joy. It's no wonder that families welcoming their newest members are looking for high-quality health care to ensure a smooth delivery and reliable postpartum care.
THE WEST SHOULD EXERT EVERY EFFORT TO MAKE RUSSIA PAY THE HIGHEST PRICE POSSIBLE FOR ITS AGGRESSIVE BEHAVIOR
RUSSIA'S FULL-SCALE INVASION of Ukraine in February 2022 awakened the worst memories for Georgians.
RUSSIA'S THREAT TO THE WORLD
As Vladimir Putin begins a fifth term as the nation's president, how safe are other countries from the Kremlin leader?
Nikki Glaser
COMEDIAN NIKKI GLASER NEVER WANTS TO OFFEND. \"I NEVER WANT TO say offensive or raunchy [things] or push the envelope, because that speaks to some kind of comedian who wants to rile people up.\"
Unraveling The Mummy After 25 Years
Its stars thought it would flop. Now a quarter of a century after its release, Arnold Vosloo, Rachel Weisz, Patricia Velásquez and Kevin J. O'Connor reflect on the cult classic
PUBLIC RELATIONS FIRMS 2024
A COMPANY'S ABILITY TO COMMUNICATE with the public is essential. Managing a firm's reputation, driving interest in its products and limiting damage during times of crisis hinge in large part on the abilities of its public relations professionals.
Work Less, Relax More
Millennials are ready for a four-day week. The younger generation wants to work fewer hours
THE INVISIBLE SCARS OF WAR
The ongoing conflict with Russia has left 10 million Ukrainians affected by mental health conditions. Now, a community-led program is giving citizens the tools they need to help them overcome their trauma
'We Are Facing the Most Complex Security Environment Since - World War II'
Japan's prime minister on security, diplomacy and protecting the rule of law at home, in Asia and around the world
Wildlife Crossings Are a Bear Necessity
Safe passages for animals under or over highways are reducing road collisions and could help them to adapt to climate change by seeking out new habitats
